Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Alliance Global Partners Downgrades T2 Biosystems to Neutral

Alliance Global Partners analyst Ben Haynor downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.
byBenzinga Newsdesk
July 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Alliance Global Partners analyst Ben Haynor downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Vaxart Announces Topline Data From The Phase 2 Challenge Study Of Its Monovalent Norovirus Vaccine Candidate; Study Met 5 Of 6 Primary Endpoints; Vaccine Was Safe And Well Tolerated With No Vaccine-related Serious Adverse Events

By Happy Mohamed
September 6, 4:30 PM
Study met 5 of 6 primary endpoints   Vaccine was safe and well tolerated with no vaccine-related serious adverse events (SAEs) Vaccination led to a statistically significant reduction in infection rate, a

VXRT